Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Lal PathLabs Limited
  6. News
  7. Summary
    539524   INE600L01024

DR. LAL PATHLABS LIMITED

(539524)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Dr. Lal Pathlabs Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020

01/29/2021 | 05:32am EDT

Dr. Lal PathLabs Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 4,659 million compared to INR 3,417 million a year ago. Net income was INR 945 million compared to INR 541 million a year ago. Basic earnings per share from continuing operations was INR 11.44 compared to INR 6.56 a year ago. Diluted earnings per share from continuing operations was INR 11.41 compared to INR 6.55 a year ago. For the nine months, total revenue was INR 11,881 million compared to INR 10,717 million a year ago. Net income was INR 2,082 million compared to INR 1,934 million a year ago. Basic earnings per share from continuing operations was INR 25.23 compared to INR 23.48 a year ago. Diluted earnings per share from continuing operations was INR 25.16 compared to INR 23.42 a year ago.


ę S&P Capital IQ 2021
All news about DR. LAL PATHLABS LIMITED
10/26Dr. Lal PathLabs' Consolidated Profit Climbs in Fiscal Q2 But Misses Estimates
MT
10/26Dr. Lal PathLabs to Acquire Indian Diagnostics Chain for Over $123 Million
MT
08/03DR LAL PATHLABS : Nomura Adjusts Dr. Lal Pathlabs' Price Target to 2,465 Indian Rupees Fro..
MT
08/02DR LAL PATHLABS : . Lal PhathLabs' Consolidated Profit Soars in Fiscal Q1
MT
07/30Dr. Lal Pathlabs Limited Declares Interim Dividend for the Financial Year 2021-2022, Pa..
CI
07/30Dr. Lal Pathlabs Limited Reports Earnings Results for the First Quarter Ended June 30, ..
CI
07/29Dr. Lal PathLabs Limited Approves Dividend for the Financial Year Ended March 31, 2021
CI
07/06Dr. Lal Pathlabs Limited to Declare Dividend for the Financial Year Ended March 31, 202..
CI
06/18Suburban Diagnostics Reportedly in Sale Talks with Dr. Lal PathLabs, Metropolis, Pharme..
CI
05/24DR LAL PATHLABS : Nomura Adjusts Dr. Lal Pathlabs' Price Target to 2,345 Indian Rupees Fro..
MT
More news
Analyst Recommendations on DR. LAL PATHLABS LIMITED
More recommendations
Financials
Sales 2022 20 094 M 268 M 268 M
Net income 2022 3 992 M 53,2 M 53,2 M
Net cash 2022 11 446 M 152 M 152 M
P/E ratio 2022 73,2x
Yield 2022 0,53%
Capitalization 290 B 3 873 M 3 867 M
EV / Sales 2022 13,9x
EV / Sales 2023 12,8x
Nbr of Employees 3 996
Free-Float 37,5%
Chart DR. LAL PATHLABS LIMITED
Duration : Period :
Dr. Lal PathLabs Limited Technical Analysis Chart | 539524 | INE600L01024 | MarketScreener
Technical analysis trends DR. LAL PATHLABS LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 3 513,55 INR
Average target price 3 074,78 INR
Spread / Average Target -12,5%
EPS Revisions
Managers and Directors
Bharath Uppiliappan Chief Executive Officer
Ved Prakash Goel Chief Financial Officer
Arvind Lal Executive Chairman
Munender Soperna Chief Information Officer
Rajat Kalra Secretary, Compliance Officer & Head-Legal
Sector and Competitors